Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (961-970 of 1,060) with videos related to

Pageof 106
Sort By:
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
European Journal of Heart Failure|November 17, 2022
Health-related quality of life outcomes in PARAGON-HFAlvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Journal of Hazardous Materials|March 14, 2025
Companion animals as sources of hazardous critically important antimicrobial-resistant Escherichia coli: Genomic surveillance in ShanghaiYiwen Chen, Min Li, Bingqing Sun, et al.
European Heart Journal|June 26, 2023
Stroke in patients with heart failure and reduced or preserved ejection fractionMingming Yang, Toru Kondo, Jawad H Butt, et al.
Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|January 2, 2025
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 TrialsHenri Lu, Toru Kondo, Brian L Claggett, et al.
JACC. Heart Failure|November 21, 2024
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF TrialFinnian R Mc Causland, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure|January 6, 2022
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failureFinnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
European Journal of Heart Failure|February 28, 2014
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fractionMauro Gori, Carolyn S P Lam, Deepak K Gupta, et al.
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Pageof 106

Showing results (961-970 of 1,060) with videos related to

Sort By:
Pageof 106
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
European Journal of Heart Failure|November 17, 2022
Health-related quality of life outcomes in PARAGON-HFAlvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
Journal of Hazardous Materials|March 14, 2025
Companion animals as sources of hazardous critically important antimicrobial-resistant Escherichia coli: Genomic surveillance in ShanghaiYiwen Chen, Min Li, Bingqing Sun, et al.
European Heart Journal|June 26, 2023
Stroke in patients with heart failure and reduced or preserved ejection fractionMingming Yang, Toru Kondo, Jawad H Butt, et al.
Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|January 2, 2025
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 TrialsHenri Lu, Toru Kondo, Brian L Claggett, et al.
JACC. Heart Failure|November 21, 2024
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF TrialFinnian R Mc Causland, Muthiah Vaduganathan, Brian Claggett, et al.
European Journal of Heart Failure|January 6, 2022
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failureFinnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
European Journal of Heart Failure|February 28, 2014
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fractionMauro Gori, Carolyn S P Lam, Deepak K Gupta, et al.
European Journal of Heart Failure|December 30, 2021
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HFJames P Curtain, Alice M Jackson, Li Shen, et al.
Pageof 106